Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
2San is a private, active healthcare company focused on consumer-facing self-diagnostics, rapid testing, and related digital health solutions. The company markets easy-to-use home testing products across categories including infection, health and wellness, family planning, drugs of abuse, and water testing, and positions itself as a global diagnostics business serving pharmacy chains, healthcare institutions, governments, and commercial customers. In addition to branded self-test products, 2San also describes capabilities in infection control, medical consumables, and digital product support. The business appears to have been formed during the COVID-19 pandemic and has expanded internationally across the US, UK, Europe, and APAC. 2San is not a therapeutics developer; it is better characterized as a commercial-stage diagnostics and healthcare products company built around accessible home-testing and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 2San.